Prognostic Importance of the Soluble Form of IL-2 Receptor^|^alpha; (sIL-2R^|^alpha;) and its Relationship with Surface Expression of IL-2R^|^alpha; (CD25) of Lymphoma Cells in Diffuse Large B-cell Lymphoma Treated with CHOP-like Regimen with or without Rituximab : A Retrospective Analysis of 338 Cases-Reference-Cited by-同舟云学术

Prognostic Importance of the Soluble Form of IL-2 Receptor^|^alpha; (sIL-2R^|^alpha;) and its Relationship with Surface Expression of IL-2R^|^alpha; (CD25) of Lymphoma Cells in Diffuse Large B-cell Lymphoma Treated with CHOP-like Regimen with or without Rituximab : A Retrospective Analysis of 338 Cases

Published:2013 Issue:3 Volume:53 Page:197-205
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Hashimoto Yoko,Yokohama Akihiko,Saitoh Akio,Nakahashi Hirotaka,Toyama Kohtaro,Mitsui Takeki,Koiso Hiromi,Saitoh Takayuki,Handa Hiroshi,Uchiumi Hideki,Jinbo Takahiro,Murayama Kayoko,Matsumoto Morio,Sawamura Morio,Karasawa Masamitsu,Murakami Hirokazu,Hirato Junko,Nojima Yoshihisa,Kojima Masaru,Tsukamoto Norifumi

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Reference31 articles.

1. 1 A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993

2. 2 Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947, 2002

3. 3 Niitsu N, Okabe-Kado J, Okamoto M, Takagi T, Yoshida T, et al.: Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 97:1202-1210, 2001

4. 4 Nyman H, Adde M, Karjalainen-Lindsberg ML, Taskinen M, Berglund M, et al.: Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 109:4930-4935, 2007

5. 5 Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, et al.: Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci 100:1842-1847, 2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies;Experimental & Molecular Medicine;2024-01-05

2. Biological functions and therapeutic opportunities of soluble cytokine receptors;Cytokine & Growth Factor Reviews;2020-10

3. Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review;Leukemia;2020-07-10

4. Measurement of the concentration of serum soluble interleukin-2 receptor alpha chain in dogs with lymphoma;Veterinary Immunology and Immunopathology;2020-07

5. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse;Pathology & Oncology Research;2019-11-25